Segment Information (Tables)

3 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Schedule of segment information

	Cannabis and Medical Marijuana Segment		Facility Operations Related			Corporate and Eliminations			Consolidated
Three months ended March 31, 2022
Net revenue	$	9,017	$	1,839,881		$	-		$	1,848,898
Operating income (loss)		5,491		187,150			(161,265	)		31,376
Interest income		-		-			14,353			14,353
Interest expense		-		10,386			7,821			18,207
Property additions		-		27,902			-			27,902
Depreciation and amortization		-		15,368			522			15,890
Total assets		879,789		2,411,343			1,545,786			4,836,918
Three months ended March 31, 2021
Net revenue	$	10,871	$	1,309,753		$	-		$	1,320,624
Operating income (loss)		6,125		(3,946	)		(166,922	)		(164,743	)
Interest income		-		-			16,489			16,489
Interest expense		-		8,498			3,572			12,070
Property additions		-		6,595			1,264			7,859
Depreciation and amortization		-		7,960			1,461			9,421
Total assets		1,005,990		2,124,769			1,644,546			4,775,305

Reconciliation of revenue from segments to consolidated

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

	Three Months Ended March 31,
	2022			2021
Operating income (loss)	$	31,376		$	(164,743	)
Gain (loss) on investment in securities		(42,680	)		4,849
Paycheck Protection Program Loan forgiveness		-			10,000
Interest income		14,353			16,489
Interest expense		(18,207	)		(12,070	)
Gain (loss) on ROU asset disposal		26,168			(643	)
Other Income (expense)		1,500			(1,053	)
Income before income taxes	$	12,510		$	(147,171	)